John Wilson
About John Wilson
John Wilson is a prominent figure in the biotechnology sector, serving as the Co-Founder and CEO of Marker Therapeutics from 2015 to 2018 and currently as a Director. He has over 30 years of experience in biotechnology product design and development, and he is actively involved in various initiatives aimed at advancing cell and gene therapy manufacturing.
Work at Marker Therapeutics
John Wilson serves as the Co-Founder and Director of Marker Therapeutics, Inc., having held the position of CEO from 2015 to 2018. He has been with the company since its inception in 2015, contributing to its strategic direction and growth over the past nine years. Under his leadership, Marker Therapeutics has focused on advancing cell and gene therapy technologies.
Education and Expertise
John Wilson holds a Bachelor of Science degree in Mechanical Engineering from the University of Minnesota. He also earned a Bachelor of Arts in Business Administration and a Bachelor of Arts in Economics from Hamline University. His educational background supports his extensive experience in biotechnology product design and development, particularly in cell and gene therapy.
Background
John Wilson has over 30 years of experience in biotechnology, with a specific focus on cell and gene therapy. He has co-founded multiple companies, including AlloVir and ScaleReady, and has played significant roles in advancing manufacturing technologies in the field. His career includes positions such as Managing Director at ViraCyte, LLC, and a principal mechanical engineer at Cellex Biosciences.
Achievements
John Wilson is a co-inventor of the CELLineTM product line and the G-Rex® platform. He has obtained over 50 patents related to biotechnology, with numerous additional patents pending. His contributions include the development of the CellReady initiative, which provides a quality management system and CMC sections to facilitate FDA reviews for cell and gene therapy companies.
Current Roles and Initiatives
In addition to his work at Marker Therapeutics, John Wilson is the Founder and CEO of Wilson Wolf Manufacturing Corporation, where he has focused on simplifying cell and gene therapy manufacturing since 1995. He is also a co-founder and board member at ScaleReady, established in 2020, and the Founder and Board Member of the Wilson Foundation Minnesota since 2022.